Docplanner acquires Jameda, Germany’s largest on-line healthcare market

The world’s largest on-line healthcare market, Docplanner is investing important capital and sources into new acquisition Jameda.

As a part of the deal, Docplanner will add greater than 200 new crew members to Jameda, investing greater than 1 / 4 of a billion euros within the German market over the subsequent three years.

Munich-based Jameda, Germany’s greatest on-line healthcare market from Hubert Burda Media, companions with over 20,000 medical doctors.

Its platform usually attracts eight million sufferers, which can be added to Docplanner’s world consumer base of 110,000 medical doctors and 70 million month-to-month sufferers.

Docplanner, the digital well being unicorn, will concentrate on rising the corporate’s gross sales, buyer care and advertising groups.

The acquisition is Docplanner’s first main transfer into a brand new territory for 4 years. In 2017, the corporate arrange in Mexico and Brazil.

The firm has attained the widest geographic attain within the digital healthcare house worldwide.

Docplanner’s markets generate greater than 50% of all healthcare expenditures in Europe and 84% in Latin America. Previous acquisitions embrace markets in Italy, Spain and Turkey.


The mission of creating the digital healthcare expertise extra human, with ease-of-use continues.

Valuable time financial savings may end up in an environment friendly use of digital healthcare apps and software program to cut back the backlog between healthcare professionals and sufferers.

Facilitating scheduling, reserving, communication and funds can optimise affected person circulation, and cut back no-shows.

On the Jameda calendar, medical doctors can optimise their appointment administration, saving money and time – and spend extra time with sufferers as an alternative of on admin work.


Docplanner creates digital apps and software program options for medical doctors, clinics, hospitals and sufferers. The organisation has a community of just about two million healthcare professionals, with 100,000 clients worldwide and has places of work in additional than 12 international locations.

More than seven million appointments are booked on Docplanner per 30 days and the web sites are visited by 70 million sufferers.

Docplanner’s newest funding spherical in August valued the corporate at greater than $1 billion (€0.89M).


“Germany is home to the biggest economy in Europe, yet doctors are still too often overwhelmed by patient demand. In fact, 40-50% of calls from patients currently go unanswered and lots of time gets wasted on admin. Our goal is to help them optimise their daily routine,” Docplanner founder and CEO, Mariusz Gralewski informed MobiHealthNews.

“We are there to assist medical doctors world wide, and Germany isn’t any exception. We will enhance the best way they impart with their sufferers, beginning with on-line bookings, chat performance, automated reminders and extra. We’ll even be working to enhance the supply of digital well being data and the check-in course of.”

Dr Florian Weiss, CEO at Jameda mentioned: “We make healthcare extra human by liberating medical doctors from administrative duties, thereby serving to them spend extra time with their sufferers. Equally, we’re additionally making your entire affected person journey extra hassle-free and pleasing by growing digital instruments that facilitate the interplay between medical doctors and sufferers.

“Both corporations began with the imaginative and prescient of connecting sufferers with the perfect medical doctors after which developed to allow sufferers to simply and digitally schedule appointments. For this to be achieved, each corporations needed to create digital observe administration software program and telemedicine instruments.

“Making healthcare more human has always been at the heart of what we do, and our partnership with Docplanner will enable us to turn that vision into reality much more rapidly and in a more powerful way.”

Tips for Traveling When You Have Peripheral Artery Disease

Lungi Ngidi Ruled Out Of Netherlands Odis After Testing COVID-19 Positive; Replacement Named